Why Attend

We have live translation of all sessions in English and Portuguese.

Pre-Event Workshop
PREVENTIVE HEALTH AND WELLBEING IN BEEF AND DAIRY CATTLE
SOLD OUT
Monday, May 28th | 16:00 – 19:00pm
This is an exclusive opportunity for innovative companies, Key Opinion Leaders and researchers in Latin America to partner with a leading global animal health company. Boehringer Ingelheim are world leaders in prevention through their portfolio of vaccines and antiparasitics and have one of the highest levels of investment in the creation of future solutions in these areas.
Attendees to this workshop should be experts in the areas of prevention and wellbeing in beef and dairy cattle and should contribute to a state-of-the-art debate as to actionable solutions to advance these areas and can expect to work together with Boehringer Ingelheim senior executives in the early assessment of high potential opportunities and action plans around collaboration and strategic partnerships.
LatAm start-up companies or academic researchers only. All 30 places are now SOLD OUT
NEW FOR 2018!
Extended Innovation Showcase
Our Organising Committee will select twelve companies from our list of applications to present to our audience on-site:
- 6 companies will be chosen from small-mid-sized companies from within Latin America that are actively looking for investment or acquisition opportunities.
- 6 companies will be chosen from the US, Europe and other regions that are looking to bring new, innovative products to the Latin American market.
CONGRATULATIONS TO THE 12 FINALISTS!
>> Read all about them in the 'Showcase Finalists 2018' PDF below, in the Resources section
Who Attends?

Global Advisory Board
Joachim Hasenmaier, born 1960 in Vaihingen/Enz, Germany, DVM., is Member of the Board of Managing Directors of C.H. Boehringer Sohn AG & Co. KG since October 1, 2012, responsible for the Corporate Board Division Consumer Health Care and Animal Health. His nationality is German.
He received a veterinary medical degree (DVM) in 1986 from Ludwig-Maximilians-University, Munich, where he entered into a microbiological research program until 1989 receiving his Doktor med. vet. (PhD) degree. He completed his education with a Master in Management from Kellogg Business School, Chicago, USA in 1991. Prior to joining BI he worked in various positions for various international companies in Germany, Japan, Mexico and Brazil.
In 2002 he joined Boehringer Ingeheim as Corporate Senior Vice President for Boehringer Ingelheim Animal Health. In 2011 he took over the regional responsibilty for Prescription Medicine in NECAR (UK/Ireland, Nordics, Benelux, Canada, Australia/New Zealand). He held this position until he became Member of the Board of Managing Directors at C.H. Boehringer Sohn AG & Co. KG in October 2012.
Clint Lewis is executive vice president and president of International Operations at Zoetis. In this role, he oversees the management of the livestock and companion animal business markets outside the United States.
Mr. Lewis previously served as president, U.S. Operations at Zoetis and in the Pfizer Animal Health organization. He joined Pfizer Animal Health in 2007.
Mr. Lewis joined Pfizer in 1988 as a sales representative in Long Island, N.Y., and has held positions of increasing responsibility in several areas across various commercial operations dedicated to human health prior to joining animal health, including vice president and general manager of Pfizer’s U.S. Anti-Infectives/HIV business unit.
In 2011, Mr. Lewis was elected chairman of the Animal Health Institute (AHI) for the 2011-12 term. A member of AHI since 2007, Mr. Lewis previously served as AHI vice chair for the 2009-2010 term. AHI is the trade association for the animal health industry in the U.S. advocating on various issues important to the industry, including efficient and effective regulatory and approval processes by the U.S. Department of Agriculture (USDA), the Food and Drug Administration (FDA), and the Environmental Protection Agency (EPA).
Mr. Lewis holds a bachelor’s degree in biology from Fairfield University and a Master of Business Administration in marketing from Fairleigh Dickinson University.
Dr. Dirk Ehle has been a member of the Bayer HealthCare Executive Committee and responsible for the Animal Health Division since May 1, 2012.
Dirk Ehle was born on May 26, 1969, in Cologne, Germany. He studied law at the universities of Freiburg, Aix-en-Provence (France), Wurzburg, and New York (USA).
After three years in law firms, Dirk Ehle started his career at Bayer in 2001 in the Law Department of Bayer HealthCare. In 2006, Ehle transferred to Bayer AG’s Corporate Office where he worked as Executive Assistant to the Chairman of the Board of Management. He was also in charge of Corporate Policy & Advocacy as of 2008. In 2010, Ehle was appointed Senior Bayer Representative for Central Eastern Europe and Bayer HealthCare Representative for Poland.
Dirk Ehle is married with three children.
Dr. Rhodes has 28 years of accomplishments in human and animal drug discovery, development, biomedical research, and clinical veterinary medicine.
Dr. Rhodes was educated at the University of Pennsylvania School of Veterinary Medicine (VMD) and Cornell University (PhD). She has 28 years of accomplishments in human and animal drug discovery, development, biomedical research, and clinical veterinary medicine. She has an extensive background in physiology, veterinary medicine, and molecular biology. As a senior research fellow at Merck Research Laboratories for 10 years, she led pre-clinical biology evaluation of several marketed human drugs. Dr. Rhodes practiced clinical veterinary medicine for five years, with experience in both companion and farm animal practice. She worked for Merial Ltd. as director of development projects, leading project teams developing novel compounds for a variety of indications and headed new technology assessment, leading the evaluation of licensing opportunities. In April 2001, she formed AlcheraBio, a consulting, marketing, communications and contract research firm specializing in developing new drugs for animals, working with biotechnology and animal health companies, with clients in the US, European Union, Canada and Australia. AlcheraBio was acquired in 2008 by Argenta, and in 2011, Dr. Rhodes accepted a position as CEO of Aratana Therapeutics, a company developing innovative new medicines for dogs and cats, and subsequently, when the company became public (PETX) served as its Chief Scientific Officer. During her tenure, development was completed on three new pet therapeutics: two new molecules with novel mechanisms of actions were approved by the FDA, and a third drug had FDA registration completed and was approved in August, 2016. She is currently retired and an independent consultant. She is a member of the Board of Directors of ImmuCell (NASDAQ: ICCC) and the Alliance for Contraception in Dogs and Cats, serves on the Scientific Advisory Board of the Found Animals Foundation. She is an adjunct faculty member in the Graduate Animal Science program at Rutgers University.
Mr. Aaron Schacht is currently the Vice President of Global Research and Development / Regulatory Affairs at Elanco Animal Health. Prior to this, Mr. Aaron Schacht held a role of Global Brand Development Leader – Pain in Lilly Biomedicines. He was the global leader for product development and commercialization activities for LY2951742 – Lilly’s novel CGRP neutralizing antibody – a new potential treatment for prevention of Migraine and Cluster Headache. In 2012, Schacht joined Lilly Biomedicines as Senior Advisor – Strategy & Business Development for Lilly BioMedicines. His responsibilities included oversight of Therapeutic Strategy development, R&D Portfolio Management, and Business Development for Lilly BioMedicines – Lilly’s largest business unit. Past roles included serving as Executive Director, Global External R&D, at Eli Lilly and Company, where he was responsible for implementation of strategies which aim to leverage novel approaches to external partnerships to augment Lilly’s access to pharmaceutical innovation as well as Executive Director of LRL (Lilly Research Labs) Strategy, Portfolio Management and Project Management where he was responsible for strategic planning, R&D portfolio and project management. Prior to these roles, he was Director, Innovation Center in the eLilly organization where he focused on the exploration, incubation and implementation of new business models and capabilities relevant to the strategic evolution of the pharmaceutical industry. In 2002, during a short leave from Lilly, Mr. Schacht was co-founder, President and CEO of Artesian Therapeutics, a Gaithersburg, MD cardiovascular drug discovery start-up. Mr. Schacht began his career at Lilly in 1990 as a medicinal chemist, and spent 5 years in the laboratory working to discover pharmaceuticals to treat cardiovascular disorders. Schacht studied Organic chemistry at the University of Illinois, receiving his Bachelors of Science degree in 1990.
Alan has been a private equity investor for more than 25 years in roles including Senior Partner and Global Head of Healthcare at the private equity firm 3i Group plc. He was appointed to the board of 3i plc in 1993 and became CEO of 3i Nordic plc, based in Stockholm, upon the acquisition of Sweden's largest listed private equity company Atle AB in 2001. Alan has served on the boards of a number of healthcare companies, including most recently Phibro Animal Health Corporation which completed a successful initial public offering (IPO) in April 2014. Latterly he has been Managing Partner, CEO, and Chairman of the Investment Committee, of Hermes GPE, an active co-investor in private equity backed healthcare. Alan holds a Bachelor's degree in Law, an MSc in Enterprise and is a graduate of the Advanced Management Programme at INSEAD. He is Chair of the BVCA for 2016 – 2017 and previously chaired its Responsible Investment Advisory Board.
Education
- PhD, Agricultural Economics & Operations Research, Michigan State University, 1989
- DVM, Michigan State University, 1981
- BS, Fisheries & Wildlife, Michigan State University, 1978
Honors and Awards
- LGVMA Leadership Award, 2013
- President’s Honor Roll, Michigan Veterinary Medical Association, 2006, 2007, 2008, 2009, 2011
- Senior Fellow, Outreach and Engagement, Michigan State University, 2005-13
- Certificate of Appreciation, Assoc. of Vet. Practice Management Consultants and Advisors, 2004
- Norden Teacher of the Year Award Finalist, College of Veterinary Medicine, 2003
- Creativity in Teaching Award, Merck Agvet, 1995
- State Team Award, Milk Quality Assurance Program, Michigan State University Extension, 1993
- Commendation (for Extension activity), Michigan Cattlemen’s Association, 1992
- The Honor Society of Phi Kappa Phi, Michigan State University, inducted 1985
- Phi Zeta, Honorary Veterinary Society, Michigan State University, inducted 1981
- Butler Award, voted by peers as “most likely to succeed” in large animal veterinary medicine, 1981
- Honors College, Michigan State University, 1975 to 1977
Interests
Dr. Lloyd was leader of the National Commission on Veterinary Economic Issues working group on Enhancing the Skills, Knowledge, Aptitude, and Attitude of Veterinarians from 2000-2009. He also works as an organization development consultant, emphasizing strategic planning and leadership development with inclusion as a core element.
Sébastien Huron, 46, DVM, started his career in 1994 in Brazil in the Hoechst-Roussel group where he rapidly rose to become the Marketing director of the animal health division. After Intervet acquired this division (Akzo Nobel group), which was then integrated into the Merck Group, Sébastien Huron pursued his career in 2000 in the United States as Market Development director, and then as director of the Pet division. After rejoining the Virbac group in 2006 as the general manager of the Spanish subsidiary, he then became the director of the European region in 2008, and then head of Global Business Operations in 2013. He has been part of the Virbac executive board since December 2012.
In the News
We've been featured!
The March edition of Motivar Magazine features interviews with three of our headline speakers:
- Wolfgang Haag, Managing Director, Vetoquinol Brazil
- Sebastián Perretta, Business Development & Marketing Strategy Director, Biogénesis Bagó
- Fabio Paganini, Head of Latin America Region Animal Health, Boehringer Ingelheim
To read their advice and thoughts about animal health innovation in Latin America click here.
The Agenda
You can download our latest agenda here.
Simply fill in this form we'll send you a PDF version immediately. We need some information to know where to send the file and how to address our email to you.
New for 2018:
- EXTENDED INNOVATION SHOWCASE: Selected Veterinary Universities, Tech-Transfer Offices and Animal Health Start-up Companies from Latin America present their technologies, looking for global partners and investment
- INTERNATIONAL SHOWCASE: International animal health companies pitch their technologies, looking for local partners in Latin America
What else can you expect?
- ADVICE: What Innovations are Cattle Producers looking for in LatAm? What technology can make an impact on productivity?
- DISCUSSIONS: How Animal Health Companies are Using the Internet to Communicate with Veterinarians in Brazil
- NUTRITIONAL HEALTH TRENDS: Medicated Feed Additives, Probiotics and Nutraceuticals
- REGULATION ROUNDTABLE: How we can bring innovation faster to major LatAm markets? Joint government initiatives
- HOT TOPICS: How can Big Data and Analytics Improve Productivity for food producers?
- OPPORTUNITIES: Companion Animal Market Drivers in Latin America
Download the agenda to find out more...
Download 2018 Agenda
The Speakers

Ivan Fernandes
Sr. Mgr., Commercial Operations and Strategic Planning for BRA&SoLA cluster (BRA,ARG,URU,PAR,BOL,PER,ECU,CHI), responsible for Strategic Planning, Market Intelligence and Research, Strategic Pricing and Revenue Management, Product Launch flow and Field Force.
Veterinarian graduated at Universidade de São Paulo (2003), with MBAs in Project Management (2010) and Business Strategic and Economic Management (2015) at Fundação Getúlio Vargas. Executive with 15 years of experience in the animal health industry, playing technical and marketing roles in local and multinational companies. From products/business development and regulatory affairs to marketing, strategy and revenue management. Specialist in innovation management in products, services and business models.

Wolfgang Haag

Fabio Paganini

Fernanda Hoe
- Veterinary Medicine degree from Unesp - Botucatu, Brazil
- Master in Science from the University of Wisconsin, USA
- MBA from FGV, Brazil.
- More than 15 years of experience in the Animal Health Industry. Experience in technical, sales, marketing with focus on customer insights, product positioning and launching. Since 2016 leading the R&D team in Brazil.

Osvaldo Ciasulli

Luciano Aba
I have always been linked to journalism, and have worked for 15 years in the field of health and productivity for different animal species in Argentina.
I aim to highlight the work of veterinary professionals in the field and have tried to reflect in my articles the importance of good advice in everything that has to do with productivity.
The objective is to position the different media in which I work, as a generator of debates that favor the greatest growth of all the actors linked to Animal Health and Productivity.
--------
Siempre ligado al periodismo, desde ya 15 años me desempeño en el ámbito de la sanidad y la productividad de las distintas especies animales en Argentina.
Destacando siempre la labor de los profesionales veterinarios a campo, he intentado reflejar en artículos la importancia de unbuen asesoramiento en todo lo que tiene que ver con la productividad.
El objetivo es posicionar a los distintos medios en los cuales me desempeño, como generador de debates que favorezcan el mayor crecimiento de todos los actores vinculados con la Sanidad y Productividad animal.

Luiz Luccas

Bernardo Arrospide

Carolina Padovani
Carolina Padovani has been the Scientific Affairs & Communication Manager at Royal Canin Brazil since January 2016. Her backgroud is in veterinary medicine and she has a master's degree in pet nutrition. She started her career at Royal Canin with a regulatory affairs implementation area in 2010. Since then she has developed some projects and get the opportunity to navigate in different areas such as R&D, MKT, Corporate Affairs, Public Affairs. In her current position, she manages the areas of technical knowledge and relationship with KOL and universities.

Bruno Ducatti
Entrepreneur and co-creator of the company, and developer of Brazil's largest platform of online communication between companies and veterinarians. Participation in the design of new products. Acting with commercial negotiations and strategic partnerships. Expertise in mobile technology and communication and branding strategies.
-----
Empreendedor e co-criador da empresa desenvolvedora da maior plataforma do Brasil de comunicação online entre empresas e médicos veterinários. Participação na concepção de novos produtos. Atuação com negociações comerciais e parcerias estratégicas. Expertise em tecnologia mobile e em estratégias de comunicação e branding.

Sebastian Perretta
Sebastian Perretta is an Economist from the UBA and throughout his career he has worked in the business sector of the veterinary industry.
Since 2002 he has gone through different areas of the company adding experience in Accounting, Finance, Management Control, Innovation, Marketing, Marketing and Communications, which has given a very broad and strategic vision of the global veterinary industry.
In 2015, he was appointed Director of Business Development and Strategy with the objective of global diversification of the company by geography and by species.
Biogenesis Bagó is a company of Argentine capitals with which its contributions and that of its different teams have contributed for the company to be the first regional company in turnover in the segment of ruminants in Latin America.
Summing up his career, in the last five years he has accompanied the globalization stage of technologies, after having achieved consolidation in Latin America.
The business vision of the company always focused on strategically supporting the productive sectors, specifically the livestock and food production sector, with the scientific sector in betting on innovation as a way to approach business and the quality of products and services as a differential value.
During his tenure, the company was awarded important prizes such as Animal Pharm as the Best Latin American Company of the Veterinary Sector in 2014 and 2016, the "ICBC Foreign Trade 2016" Award that recognizes innovation, job creation and the ability of international companies to act , among many other distinctions of entities linked to its activity.
-----
Sebastian Perretta es Economista de la UBA y durante toda su carrera laboral se desempeñó en el sector empresarial de la industria veterinaria.
Desde 2002 ha pasado por distintas áreas de la compañía sumando experiencia en Contaduría, Finanzas, Control de gestión, Innovación, Marketing, Comercialización y Comunicaciones, lo que le ha brindado un visión muy amplia y estratégica de la industria veterinaria global.
En el año 2015 ha sido nombrado Director de Desarrollo de Negocios y Estrategia teniendo como objetivo la diversificación global de la compañía por geografía y por especies.
Biogénesis Bagó es una empresa de capitales argentinos a la que con sus aportes y el de sus diferentes equipos han contribuido para que la compañía sea la primera empresa regional en facturación en el segmento de rumiantes en Latinoamérica.
Resumiendo su trayectoria, en los últimos cinco años ha acompañado la etapa de globalización de las tecnologías, luego de haber logrado la consolidación en Latinoamérica.
La visión de negocios de la empresa siempre se enfocó en apoyar estratégicamente a los sectores productivos, específicamente al sector ganadero y de producción alimentaria, con el sector científico en apostar a la innovación como modo de encarar los negocios y a la calidad de los productos y servicios como valor diferencial.
Durante su gestión la compañía fue merecedora de premios importantes como Animal Pharm como mejor Empresa Latinoamericana del Sector Veterinario en el 2014 y 2016, Premio “ICBC Comercio Exterior 2016" que reconoce la innovación, la generación de empleo y la capacidad de actuación internacional de empresas; entre otras numerosas distinciones de entidades vinculadas a su actividad.

Roberto Cohen
Professional with unique, combined expertise in M&A transactions, business integration and operations. Deep knowledge in how to identify, oversee and run investments by US publicly traded companies in Latin America.
11 years of experience in cross-border M&A transactions, involved in every stage of the deal making process: from assessing strategic fit, determining valuation, coordinating due diligence, seeking Board approval in a Fortune-300 company environment, negotiating definitive agreements and, planning & executing post-close business integration.
Operational experience in integrating newly acquired businesses and in transitioning them from a family-owned environment into a subsidiary of a larger organization, ensuring the continuation of an entrepreneurial environment but implementing the appropriate levels of compliance at the same time.
Led Henry Schein's entry and expansion in the Brazilian Dental market by closing 2 M&A transactions and led Henry Schein's entry into the Brazilian Animal Health market by closing 1 M&A transaction
Conference Packages
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
Principal Partner
Boehringer Ingelheim
Website: http://www.boehringer-ingelheim.com
Boehringer Ingelheim is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates presently with a total of some 50,000 employees worldwide. The focus of the family-owned company, founded in 1885, is on researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine. In 2015, Boehringer Ingelheim achieved net sales of about 14.8 billion euros. R&D expenditure corresponds to 20.3 per cent of net sales.
For more information, please visit www.Boehringer-Ingleheim.com
Associate Partner
Zoetis
Website: http://www.zoetis.com
Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 65 years of experience in animal health, Zoetis discovers, develops, manufactures and commercializes medicines, vaccines and diagnostic products, which are complemented by biodevices, genetic tests and precision livestock farming. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2019, the company generated annual revenue of $6.3 billion with approximately 10,600 employees.
For more information, visit www.zoetis.com.
Event Partners
Argenta
Website: http://www.argentaglobal.com
Argenta Limited, founded in 2006, is the world’s only combined contract research organization (CRO) and contract manufacturing organization (CMO) specializing in animal health. With accredited operations and facilities across New Zealand, the United States and Scotland, Argenta is fully equipped to offer a full range of products and services - from access to innovative intellectual property, formulations research and development (R&D), analytical methods development, clinical trial management through to pilot- technical transfer and commercial-scale manufacturing - to the global animal health industry. Argenta’s 400+ global team develops and exports products and services to over 40 countries.
A privately-owned company headquartered in Auckland, New Zealand, Argenta brings innovation, R&D and manufacturing expertise together in one global company. This makes it ideally placed to accommodate unique product requirements no matter the scale or complexity. Argenta’s facilities in New Zealand, the United States (Iowa, Kansas and New Jersey) and Europe (Scotland) enable the achievement of significant efficiencies in product development and technology transfer, and to provide market intelligence and in-depth knowledge of market preferences in different countries as required.
Argenta is honoured to work with a vast range of clients globally - from small and medium-sized enterprises (SMEs) to some of the largest industry players. Argenta has the R&D capabilities and manufacturing scale to service the requirements of the largest multinationals, while, at the other end of the spectrum, Argenta works with startups and small companies with great ideas to help them find solutions and bring their ideas to fruition.
For more information, please visit www.argentaglobal.com.
Biogénesis Bagó
Website: http://www.biogenesisbago.com/en/
Biogénesis Bagó is a biotechnology company with regional and international scope and more than 80 years of experience specialized in the development, production and trade of products for the sanity and breeding of animals. Through world reference scientific innovation and the certified quality of its processes and products (GMP,ISO 9001 and 14001), Biogénesis Bagó contributes the research of veterinary solutions for a higher productive efficiency. It is the only company in the field which has the products approved to be used against the Foot and Mouth Disease (FMD) in the United States of America and Canada. Their portfolio of products includes vaccines against the FMD, a world-class product with quality and technology highly recognized that protects one every three bovines of the region and helps the monitoring of the disease in most of the countries of the area where the vaccination is carried out; biological products; inter anti parasitic drugs composed by different drugs which allow the strategic monitoring and that avoid resistance; antibacterial drugs; vitamins and minerals; and reproductive. Biogénesis Bagó technical after-sales service is a key element for the correct use of technology since it is aimed to produce more effectively with the correct handling of the resources.
Elanco
Website: http://www.elanco.com
Elanco Animal Health (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we’re driven by our vision of Food and Companionship Enriching life and our Elanco Healthy Purpose™ CSR framework – all to advance the health of animals, people and the planet.
Vetoquinol
Website: http://www.vetoquinol.co.uk
Founded in 1933, Vetoquinol is the 9th largest veterinary pharmaceutical business, committed to the protection and well-being of both animals and people.
ZENOAQ
Website: http://www.zenoaq.jp/english/index.html
ZENOAQ aims to create a shared and everlasting future for humans and animals. Amidst efforts to improve drug development, veterinary therapy and biotechnology, ZENOAQ strives to enhance the value of animals. The core activities in ZENOAQ are deeply connected with our customers, which in turn, affects their animals in many different ways. These connections form a network that is not just limited to Japan, but is something that will also reach across international borders, creating mutual benefit for both humans and animals in the future.
Media Partners
Animal Pharm | IHS Markit
Website: http://www.animalpharmnews.com
The only source of animal health and animal nutrition news and analysis you’ll ever need.
Animal Pharm gathers intelligence from across the animal health and animal nutrition industries. It keeps you abreast of critical developments, emerging trends, and changes to the business, regulatory and competitive environment.
We have been providing animal health professionals worldwide with news, analysis and insight for over 30 years, and cover the food producing animal and companion animal sectors. With extensive information on animal health products including antiparasitics, vaccines, pharmaceuticals, feed, feed additives and equipment.
Features include:
Analysis of business and company news
Reporting on key players in the industry
Market developments and trends
Analysis of the latest global regulatory changes
News on product research and development
Expert opinion and analysis
CLAMEVET
Website: http://www.clamevet.com.ar
Argentine Veterinary Laboratories Chamber (CLAMEVET) was founded in 2005 with the objectives of promoting, prestige and protect the veterinary industry and all the activities related to the production of veterinary medicinal products of national manufacture.
Nowadays, CLAMEVET brings together more than 50 veterinary laboratories of national capitals that are highly trained to guarantee the supply of veterinary products either to our market and to the rest of the world.
CLAMEVET has, among others, the following activities:
a. Organize training courses for its associates
b. Involved in technical commissions with regulatory authorities (national and international)
c. Attends every year CAMEVET’s meetings (Committee of the Americas on Veterinary Drugs), a regional project which main purpose is to facilitate the harmonization of standards for the registration of veterinary products throughout the American continent.
d. It has representation in the industrial branch of CAME (Argentine Confederation of the Medium Company)
feed&food
Website: http://www.feedfood.com.br
A Editora Ciasulli chega ao mercado com uma expertise de mais de 45 anos em jornalismo do agronegócio e em meio aos dez anos de edição da publicação feed&food, porta-voz da agroindústria da cadeia de proteína animal e preocupada com o abastecimento de alimentos para as 9 bilhões de bocas em 2050.
A revista mensal, somada ao portal de notícias (www.feedfood.com.br) e suas demais ferramentas, como aplicativos para Android e iOS (www.revistafeedfood.com.br), e projeto paralelos, tem como objetivo a atualização de conhecimento para todos os profissionais ligados à cadeia de proteína de origem animal, seja na área de avicultura (corte e postura), suinocultura, bovinocultura (corte e leite), aquacultura e todo o segmento food; servindo como ponte de discussão e entrosamento entre entidades, governo e iniciativa privada.
Missão: Disseminar informações que promovam conhecimento focado em segurança alimentar.
Visão: Informar e inspirar leitores a transformarem o conhecimento em ações práticas em prol das gerações de hoje e futuras.
Valores: Ética, transparência, otimismo, foco, inovação e empreendedorismo.
MOTIVAR
Website: http://www.motivar.com.ar
MOTIVAR es el primer periódico íntegramente dedicado al análisis del sector veterinario argentino. Tal es así que desde hace años nos encontramos directamente involucrados en la problemática de un mercado en el cual nuestro nombre representa objetividad y confianza para más de 5.000 lectores de todo el país, los cuales reciben mensualmente nuestra publicación de manera gratuita y personalizada.
En la actualidad, MOTIVAR es distribuido en distintas esferas:
Sector Público
- Ministerio de la Producción (Técnicos).
- Secretaría de Agricultura, Ganadería, Pesca y Alimentación de la Nación. (Funcionarios, técnicos, asesores y prensa).
- SENASA (Presidencia, Consejo de Administración, Direcciones nacionales y prensa).
Sector Industrial
- Más de 200 laboratorios de todo el país (Presidencia, gerencia, director técnico, ventas, marketing, compras y asesores).
- Veterinarios y Productores.
- Productores nacionales (Asociaciones, federaciones y fundaciones ligadas a bovinos, porcinos, avicultura, ovinos, equinos, etc).
- Más de 3.000 veterinarios de todo el país, Colegios y Consejos profesionales).
Sector Académico
- Facultades de Ciencias Veterinarias de todas las Universidades del país (autoridades, docentes, prensa, investigación y desarrollo y bibliotecas).
- Sectores de Investigación y Desarrollo.
- Centros públicos y privados (INTA, INTI, INCAM, CEVAN, etc).
- Proveedores de la industria.
VETsmart
Website: http://www.vetsmart.com.br
Founded in 2012, VETsmart develops websites and applications for the veterinary medicine sector, for both small and large animals.
Become a Sponsor
Kisaco Research provides the much-needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners.
Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.
With our extensive marketing experience and strategy, your partnership with Kisaco Research will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that’s why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.
Find out more by calling us at +44 (0)20 3696 2920 or email us at [email protected].
Venue
InterContinental São Paulo
InterContinental São Paulo
Alameda Santos, 1123
São Paulo, SP - 01419-001
Brazil
Tel: +55 11 3179 2622
www.icsaopaulo.com.br
Accommodation starts at $150 per night + tax (excluding breakfast)
To take advantage of these discounted rates please click here to book.
The discounts are available for accommodaiton booked between 28-30 May only - if you would like to book rooms outside of these dates please email [email protected] and request a PDF booking form.
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.